期刊文献+

糖化血红蛋白与糖化白蛋白在诊断2型糖尿病中的价值比较 被引量:12

Value of HbA1c and glucoprotein for diagnosis of type 2 diabetes mellitus: A comparative study
下载PDF
导出
摘要 目的探讨诊断2型糖尿病时糖化血红蛋白(HbA1c)的参考值,并对比分析糖化白蛋白(GA-L)和HbA1c对于诊断2型糖尿病的灵敏度和可靠性。方法 509例疑似2型糖尿病患者(男268例,女241例),以2003年美国糖尿病学会(ADA)标准为诊断标准。通过绘制受试者工作特征曲线(ROC曲线),分析比较GA-L及HbA1c诊断糖尿病的灵敏度和特异性。结果 HbA1c的ROC曲线的最佳切点为6.75%,灵敏度75.5%,特异度93.2%,曲线下面积0.886,阳性似然比5.45,阴性似然比0.23,阳性预测值92%,阴性预测值70%。GA-L的ROC曲线的最佳切点为17.45%,灵敏度70.1%,特异度91.6%,曲线下面积0.844。当HbA1c≥6.75%时诊断的准确性为94.9%,而GA-L≥17.45%时诊断的准确性为93.3%。结论 HbA1c≥6.75%和GA-L≥17.45%可作为诊断2型糖尿病的一种参考方法,且HbA1c的灵敏度和特异度优于GA-L。 Objective To study the reference value of HbAlc for diagnosis of type 2 diabetes mellitus(DM)and compare the sensitivity and reliability of glycosylated albumin(GA-L) and HbAlc in diagnosis of type 2 DM. Methods Five hundred and nine patients with type 2 DM(268 males and 241 females) were diagnosed according to the diagnostic criteria of American Diabetes Association (ADA). The sensitivity and reliability of GA-L and HbAlc in diagnosis of type 2 DM were analyzed and compared by plotting the receiver operating characteristic(ROC) curve for DM. Results The optimal cut point of HbAlc for diagnosis of type 2 DM was 6.75% with a sensitivity of 75.5% and a specificity of 93.2%. The area under the ROC curve was 0.886 with a positive likelihood ratio of 5.45 and a negative likelihood ratio of 0.23, a positive predictive value of 92% and a negative predicative value of 70%. The optimal cut point of GA-L was 17.45% with a sensitivity of 70.1% and a specificity of 91.6%. The area under the ROC curve was 0.844. When the optimal cut point of HbAlc and GA-L was I〉 6.75% and ~〉 17.45%, its diagnosis accuracy was 94.9% and 93.3% respectively. Conclusion The HbAlc /〉 6.75% and GA-L I〉 17.45% can be used the reference values for the diagnosis of type 2 DM. The sensitivity and specificity of HbAlc are higher than those of GA-L in diagnosis of type 2 DM.
出处 《军医进修学院学报》 CAS 2012年第2期158-160,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 糖化血红蛋白 糖化白蛋白 糖尿病 葡萄糖耐量试验(OGTT) 受试者工作特征曲线(ROC) glycated hemoglobin glycated albumin diabetes mellitus oral glucose tolerance test receiver operating characteristic curve
  • 相关文献

参考文献8

  • 1American Diabetes Association. Standards of medical care in diabetes--2007 [ J ] . Diabetes Care, 2007, 30 Suppl 1 : S4-S41.
  • 2The DECODE Study Group on behalf of European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes?Epidemiological data from 20 European studies [ J ] . Diabetologia, 1999, 42 (6): 647-654.
  • 3Deepa R, Shanthi Rani S, Premalatha G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians--the Chennai Urban Population Study. American Diabetes Association [ J ] . Diabet Med, 2000, 17 ( 12 ) : 872-874.
  • 4Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, et al. Lack of agreement between the World Health Organization Category of impaired glucose toler/mce and the American Diabetes Association category of impaired fasting glucose [ J ] . Diabetes Care, 1998, 21 ( 11 ) : 1886-1888.
  • 5Bennett CM, Guo M, Dharmage SC. HbA ( lc ) as a screening tool for detection of Type 2 diabetes : a systematic review [ J ] . Diabet Med, 2007, 24 (4) : 333-343.
  • 6American Diabetes Association. Standards of medical care in diabetes--2010 [ j ] . Diabetes Care, 2010, 33 Suppl 1 ( suppl1 ): S11-S61.
  • 7高鑫.糖尿病前期筛查的分歧与共识[J].国际内分泌代谢杂志,2008,28(2):83-85. 被引量:7
  • 8Yoshiuchi K, Matsuhisa M, Katakami N, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes [ J ] . Endocr J, 2008, 55 ( 3 ) : 503-507.

二级参考文献11

  • 1American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care, 2007,30( Suppl 1 ) :S4-S41.
  • 2International Diabetes Federation. Guideline for management of postmeal glucose 2007. Available from:http://www.idf. org.
  • 3Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care,2006,29:1909-1914.
  • 4Genuth S, Alberti KG, Bennett P,et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care ,2003,26:3160-3167.
  • 5Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997,20 : 1183-1197.
  • 6Qiao Q, Hu G, Tuomilehto J,et al. Age- and sex-specific prevalence of diabetes and impaired gXucose reguXation in 11 Asian cohorts. Diabetes Care ,2003,26 : 1770-1780.
  • 7Wild S, Roglic G,Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27 : 1047-1053.
  • 8The DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ, 1998,317 : 371-375.
  • 9Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults. The Third National Health and Nutrition Examination Survey,1988-1994. Diabetes Care,1998,21:518-524.
  • 10Lindstrom J,Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care,2003,26:725-731.

共引文献6

同被引文献78

引证文献12

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部